Please assess the completion status of the following clinical trial:

Trial Title: Effects of Ranolazine and Exercise on Daily Physical Activity Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Documented CAD diagnosis~* Stable angina ≥ 3 months~Exclusion Criteria:~* Class III or IV heart failure~* Myocardial Infarction or coronary revascularization procedure within 2 months~* QT interval \> 500ms or prescribed medication known to prolong the QTc interval~* Contraindicated Medications~* Metformin dose \> 1700mg/day~* Class Ia, Ic and III anti-arrhythmics~* CYP3A inhibitors~* Simvastatin \>20mg/day~* Severe renal disease (\< 30ml/min creatinine clearance)~* Currently on dialysis~* Lack of transportation to the exercise and testing facilities~* Implanted pacemaker that is not rate responsive

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ranolazine plus Exercise (Type: ACTIVE_COMPARATOR): Ranolazine 1000mg pill twice per day plus aerobic exercise three times per week, 45 minutes per session at an intensity of 10-20 beats per minute below the angina threshold.
- Placebo plus Exercise (Type: PLACEBO_COMPARATOR): Placebo pill twice per day plus aerobic exercise three times per week, 45 minutes per session at an intensity of 10-20 beats per minute below the angina threshold.

Based on this trial design, predict the completion outcome and termination type (if applicable).